How to achieve sustained and complete protein release from PLGA-based microparticles?

被引:213
作者
Giteau, A. [1 ,2 ]
Venier-Julienne, M. C. [1 ,2 ]
Aubert-Pouessel, A. [3 ]
Benoit, J. P. [1 ,2 ]
机构
[1] INSERM, U 646, F-49100 Angers, France
[2] Univ Angers, F-49100 Angers, France
[3] ENSCM, CNRS, UM 1, UM 2,UMR 5253, F-34296 Montpellier, France
关键词
sustained release; protein; microspheres; poly(lactic-co-glycolic acid) (PLGA); in vitro release; release mechanism;
D O I
10.1016/j.ijpharm.2007.11.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
One of the most challenging tasks in the delivery of therapeutic proteins from PLGA-based microparticles is the sustained and complete release of the protein in its native form. The mechanisms responsible for incomplete protein release from these devices are numerous and complex; the beneficial effect of different formulations has often been evaluated in vitro. Strategies employed for overcoming protein destabilization during the release step are reviewed in this paper. Proteins have been protected in the deleterious environment by adding stabilizers to the formulation, or by modifying the protein or the polymer. Alternatively, some strategies have aimed at avoiding the formation of the destabilizing environment. As experimental conditions may influence the results from in vitro release studies, we initially report precautions to avoid adverse effects. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 26
页数:13
相关论文
共 105 条
[11]   Bovine serum albumin release from poly(alpha-hydroxy acid) microspheres: Effects of polymer molecular weight and surface properties [J].
Boury, F ;
Marchais, H ;
Proust, JE ;
Benoit, JP .
JOURNAL OF CONTROLLED RELEASE, 1997, 45 (01) :75-86
[12]  
Burke PA, 2000, HDB PHARM CONTROLLED, P661
[13]  
Capan Yilmaz, 2003, AAPS PharmSciTech, V4, pE28
[14]   Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein [J].
Carrasquillo, KG ;
Stanley, AM ;
Aponte-Carro, JC ;
De Jésus, P ;
Costantino, HR ;
Bosques, CJ ;
Griebenow, K .
JOURNAL OF CONTROLLED RELEASE, 2001, 76 (03) :199-208
[15]   Effect of the covalent modification with poly(ethylene glycol) on α-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic) microspheres [J].
Castellanos, IJ ;
Al-Azzam, W ;
Griebenow, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (02) :327-340
[16]   Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention [J].
Castellanos, IJ ;
Cruz, G ;
Crespo, R ;
Griebenow, K .
JOURNAL OF CONTROLLED RELEASE, 2002, 81 (03) :307-319
[17]   Protein release microparticles based on the blend of poly(D,L-lactic-co-glycolic acid) and oligo-ethylene glycol grafted poly(L-lactide) [J].
Cho, KY ;
Choi, SH ;
Kim, CH ;
Nam, YS ;
Park, TG ;
Park, JK .
JOURNAL OF CONTROLLED RELEASE, 2001, 76 (03) :275-284
[18]   Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery [J].
Chung, Hyun Jung ;
Kim, Hong Kee ;
Yoon, Jun Jin ;
Park, Tae Gwan .
PHARMACEUTICAL RESEARCH, 2006, 23 (08) :1835-1841
[19]   Microparticles of poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery [J].
Cleek, RL ;
Ting, KC ;
Eskin, SG ;
Mikos, AG .
JOURNAL OF CONTROLLED RELEASE, 1997, 48 (2-3) :259-268
[20]   Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect [J].
Cleland, JL ;
Duenas, E ;
Daugherty, A ;
Marian, M ;
Yang, J ;
Wilson, M ;
Celniker, AC ;
Shahzamani, A ;
Quarmby, V ;
Chu, H ;
Mukku, V ;
Mac, A ;
Roussakis, M ;
Gillette, N ;
Boyd, B ;
Yeung, D ;
Brooks, D ;
Maa, YF ;
Hsu, C ;
Jones, AJS .
JOURNAL OF CONTROLLED RELEASE, 1997, 49 (2-3) :193-205